Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) Interest Expenses (2016 - 2025)

International Stem Cell (ISCO) has disclosed Interest Expenses for 16 consecutive years, with $37000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses rose 5.71% to $37000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $155000.0, a 10.71% increase, with the full-year FY2024 number at $145000.0, up 4.32% from a year prior.
  • Interest Expenses was $37000.0 for Q3 2025 at International Stem Cell, down from $76000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $76000.0 in Q2 2025 to a low of $3000.0 in Q1 2025.
  • A 5-year average of $34894.7 and a median of $35000.0 in 2022 define the central range for Interest Expenses.
  • Biggest YoY gain for Interest Expenses was 117.14% in 2025; the steepest drop was 91.67% in 2025.
  • International Stem Cell's Interest Expenses stood at $39000.0 in 2021, then decreased by 15.38% to $33000.0 in 2022, then grew by 3.03% to $34000.0 in 2023, then rose by 14.71% to $39000.0 in 2024, then dropped by 5.13% to $37000.0 in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Interest Expenses are $37000.0 (Q3 2025), $76000.0 (Q2 2025), and $3000.0 (Q1 2025).